Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-05

Clinical Trial Update: Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum Malaria [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of the amodiaquine-artesunate combination in treating uncomplicated Plasmodium falciparum malaria in children aged 6-59 mo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amodiaquine + Artesunate

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Malaria | Phase 4 | Status: COMPLETED